morpholine has been researched along with pyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, EM; Jorgensen, WL | 1 |
| Fotsch, C; St Jean, DJ | 1 |
| Cherian, PT; Knittel, JJ; Koikov, LN; Wortman, MD | 1 |
1 review(s) available for morpholine and pyridine
| Article | Year |
|---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
2 other study(ies) available for morpholine and pyridine
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Exploring the PI3K alpha and gamma binding sites with 2,6-disubstituted isonicotinic derivatives.
Topics: Binding Sites; Catalytic Domain; Class Ib Phosphatidylinositol 3-Kinase; Class II Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Isoenzymes; Isonicotinic Acids; Models, Molecular; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Pyridines | 2009 |